Vaccine Research Market Research Report By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Conjugate Vaccines, Subunit Vaccines, Viral Vector Vaccines, DNA Vaccines, mRNA Vaccines), By Disease Prevention (Infectious Diseases (e.g., Measles, Polio, Influenza), Chronic Diseases (e.g., Cancer, HIV/AIDS), Rare Diseases (e.g., Cystic Fibrosis, Hemophilia)), By Target Population (Pediatrics, Adults, Elderly, Pregnant Women), By Delivery Method (Intramuscular Injection, Subcutaneous Injection, Intranasal Deliver

Global Vaccine Research Market Overview

As per MRFR analysis, the Vaccine Research Market Size was estimated at 38.69 (USD Billion) in 2022.

The Vaccine Research Industry is expected to grow from 44.46 (USD Billion) in 2023 to 155.3 (USD Billion) by 2032. The Vaccine Research Market CAGR (growth rate) is expected to be around 14.91% during the forecast period (2024 - 2032).

Key Vaccine Research Market Trends Highlighted

Key market drivers include the rising incidence of infectious diseases, increased government funding and support for vaccine research, technological advancements, and strategic collaborations among stakeholders.Opportunities to be explored or captured include personalized vaccines, mRNA and DNA vaccines, and vaccines for neglected diseases. Trends in recent times include the emergence of precision medicine, the convergence of AI and machine learning, the use of novel delivery systems, and the growing focus on vaccine equity and accessibility. 

Personalized vaccines address individual genetic and immune profiles, improving vaccine efficacy and reducing side effects. mRNA and DNA vaccines offer rapid and flexible production, enabling faster response to emerging pathogens. mRNA vaccines have already proven their effectiveness against COVID-19. Vaccines for neglected diseases address unmet medical needs in resource-limited settings, reducing disease burden and improving global health. 

Advances in delivery systems enhance vaccine stability, delivery efficiency, and immune response. AI and machine learning accelerate vaccine discovery and development, identifying targets, optimizing formulations, and predicting immune responses.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Vaccine Research Market Drivers

Increasing Prevalence of Infectious Diseases

One of the key drivers of the Vaccine Research Market Industry is the accelerating rise of infectious diseases across the globe. The growth of the world’s population, urbanization, and an increasing number of people who engage in global travel facilitate the spread of various diseases. 

Therefore, to reduce morbidity rates that are expected to grow along with the number of infectious diseases, vaccinations become vital. Developing more effective vaccines is critical to reducing the threat to human health, and under these conditions, the Vaccine Research Market Industry will continue to grow.

Government Support for Vaccine Research

Another factor expected to propel the Vaccine Research Market Industry is government support. Governments worldwide are providing support to engage in vaccine research to develop new and better vaccines. Such government support is crucial in the Vaccine Research Industry since it funds the development of vaccines and the production of the same, which may be made available to the public at subsidized rates due to the support. Government support may be in the form of research grants, tax benefits, or regulatory support.

Advancements in Vaccine Technology

The growth of the Vaccine Research Market Industry is also due to the advances in vaccine technology. With the new technologies, such as mRNA vaccines and different gene editing, it is possible to create new vaccines that are more efficient and safer. 

At least, it is expected that these advances will help to create more vaccines against the wide spectrum of diseases. The Vaccine Research Market Industry will benefit from the vaccine technology advancement.

Vaccine Research Market Segment Insights

Vaccine Research Vaccine Type Insights

Vaccine Type Segment Insights and Overview The Vaccine Research Market is segmented by vaccine type into live attenuated vaccines, inactivated vaccines, recombinant vaccines, conjugate vaccines, subunit vaccines, viral vector vaccines, DNA vaccines, and mRNA vaccines. Live attenuated vaccines are made from a weakened or attenuated form of the virus. They are effective in stimulating a strong immune response, but they can also cause mild symptoms of the disease. Inactivated vaccines are made from a killed form of the virus. They are less effective than live attenuated vaccines in stimulating an immune response, but they are also less likely to cause side effects.

Recombinant vaccines are made using genetic engineering techniques to produce a specific protein from the virus. They are highly effective and safe, but they can be more expensive to produce than other types of vaccines. Conjugate vaccines are made by linking a polysaccharide antigen to a protein carrier. They are effective in stimulating an immune response in young children who are not able to respond well to polysaccharide vaccines alone. Subunit vaccines are made from specific proteins or antigens from the virus. They are less effective than whole-virus vaccines, but they are also less likely to cause side effects.

Viral vector vaccines are made using a harmless virus to deliver a piece of DNA from the virus that causes the disease. They are highly effective and safe, but they can be more expensive to produce than other types of vaccines. DNA vaccines are made using plasmid DNA that contains the gene for a specific protein from the virus. They are injected into the body, where they are taken up by cells and used to produce the protein. DNA vaccines are still in the early stages of development, but they have the potential to be highly effective and safe.mRNA vaccines are made using messenger RNA (mRNA) that encodes a specific protein from the virus. 

They are injected into the body, where they are taken up by cells and used to produce the protein. mRNA vaccines are still in the early stages of development, but they have the potential to be highly effective and safe. The Vaccine Research Market is expected to grow significantly in the coming years, driven by the increasing demand for new and improved vaccines to prevent and treat infectious diseases. The market is also expected to benefit from the development of new technologies, such as mRNA vaccines and DNA vaccines.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Vaccine Research Disease Prevention Insights

Infectious diseases, chronic diseases, and rare diseases all pose significant threats to global health. The Vaccine Research Market for disease prevention is expected to witness substantial growth in the coming years, driven by rising disease prevalence and increasing healthcare expenditure. The infectious disease segment is expected to hold a dominant share of the market, owing to the high incidence of diseases such as measles, polio, and influenza. Chronic diseases, such as cancer and HIV/AIDS, are also major contributors to the market growth.

Rare diseases, though less common, can have devastating effects on patients and families, and there is a growing need for effective vaccines to prevent these conditions. Government initiatives, public-private partnerships, and technological advancements are key factors driving the growth of the disease prevention segment. Governments worldwide are investing heavily in vaccine research and development to improve public health outcomes. Public-private partnerships are also playing a crucial role in accelerating vaccine development and ensuring equitable access to vaccines.

Technological advancements, such as mRNA and DNA-based vaccines, are also contributing to the development of more effective and personalized vaccines. The market is highly competitive, with several key players investing in research and development. 

Leading companies are focusing on developing novel vaccines, optimizing existing vaccines, and expanding their geographical reach. Mergers and acquisitions are also shaping the competitive landscape as companies seek to consolidate their market position and gain access to new technologies.

Vaccine Research Target Population Insights

The Target Population segment plays a crucial role in shaping the Vaccine Research Market revenue and segmentation. It categorizes the market based on the specific population groups targeted by vaccines. Pediatrics: This segment holds a significant share in the Vaccine Research Market due to the high demand for vaccines to prevent childhood diseases such as measles, mumps, and rubella. 

Adults: The adult population represents a growing segment in the Vaccine Research Market, driven by the increasing prevalence of chronic diseases and the need for booster vaccinations.

Elderly: The elderly population is another important segment, as they are more susceptible to vaccine-preventable diseases due to weakened immune systems. 

Vaccines targeting conditions like pneumonia and influenza are in high demand in this segment. 

Pregnant Women: Vaccines for pregnant women are crucial to protect both the mother and the developing fetus from infections. 

Research efforts are focused on developing safe and effective vaccines for this population. 

Overall, understanding the Target Population segment helps vaccine manufacturers tailor their products and strategies to meet the specific needs of each group, driving market growth and improving global health outcomes.

Vaccine Research Delivery Method Insights

The Delivery Method segment of the Vaccine Research Market is segmented into Intramuscular Injection, Subcutaneous Injection, Intranasal Delivery, and Oral Administration. Intramuscular Injection holds the largest share of the market. Subcutaneous Injection is expected to witness significant growth during the forecast period. Intranasal Delivery and Oral Administration are also expected to contribute significantly to the market growth. 

The Vaccine Research Market revenue from Intramuscular Injection is projected to reach USD 65.2 billion by 2024, accounting for 42.3% of the Vaccine Research Market revenue.

Subcutaneous Injection is expected to generate USD 32.1 billion in revenue by 2024, growing at a CAGR of 11.5%. Intranasal Delivery and Oral Administration are expected to contribute USD 22.7 billion and USD 17.4 billion, respectively, to the Vaccine Research Market revenue by 2024.

Vaccine Research Regional Insights

Regionally, North America held the largest market share in 2023, accounting for around 40% of the global market. Europe stood as the second-largest market, followed by APAC, South America, and MEA. The growth in North America can be attributed to factors such as the presence of leading pharmaceutical companies, high healthcare expenditure, and government initiatives to promote vaccine research. 

The APAC region is anticipated to witness the fastest growth during the forecast period due to rising investments in healthcare infrastructure, increasing prevalence of infectious diseases, and the growing population.

South America and MEA are also expected to contribute to the overall market expansion, driven by government initiatives to improve healthcare systems and combat infectious diseases.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Vaccine Research Market Key Players And Competitive Insights

Key players in Vaccine Research Market are continuously focusing on developing novel vaccines for addressing needs of the patients. Leading firms are also forming partnerships with academic and research institutions to expedite vaccine development. Vaccine Research Market is anticipated to have significant revenue growth in the next five years due to the rising prevalence of various infectious diseases, increasing government support for research on vaccines, and technological advancements in the development of vaccines. The competitive landscape of the Vaccine Research Market will include large multinational companies as well as small and medium-sized firms.

Pfizer is one of the dominant players operating in the Vaccine Research Market and has a wide range of vaccines for a number of different diseases. The company has a strong pipeline for R and continues to develop new vaccines. Pfizer also has a strong market position and is able to sell its vaccines in over 150 nations across the globe. The company’s superior financial standing, well-developed distribution chain, and market position enable it to be one of the key players in the Vaccine Research Market.

Merck is another major company that is actively involved in research, development, and manufacturing of vaccines. The firm has a long record of developing vaccines and is known for its various vaccine technologies. The product range of Merck is also extensive and covers vaccines for various diseases such as measles, mumps, rubella, and polio. The market coverage of Merck is also strong as its vaccines are available in over 140 countries. However, its ability to invest in R and develop innovative vaccines helps Merck to stay one of the leading players in the Vaccine Research Market.

Key Companies in the Vaccine Research Market Include

• Merck Co., Inc.


• Regeneron Pharmaceuticals, Inc.


• Johnson Johnson


• Biotechnology Innovation Organization (BIO)


• Abbott Laboratories


• Novavax, Inc.


• AstraZeneca


• Vaxcyte, Inc.


• Sanofi Pasteur


• GlaxoSmithKline


• Serum Institute of India Pvt. Ltd.


• Moderna, Inc.


• Inovio Pharmaceuticals, Inc.


• Eli Lilly and Company


• Pfizer Inc.

Vaccine Research Industry Developments

The Vaccine Research Market size was valued at USD 44.46 billion in 2023 and is projected to expand at a CAGR of 14.91% to reach USD 155.3 billion by 2032. The market growth is attributed to the increasing prevalence of infectious diseases, rising government funding for vaccine development, and the development of innovative vaccine technologies.Recent news developments in the market include: Moderna and Merck announced a collaboration to develop a personalized cancer vaccine. 

Pfizer and BioNTech initiated a clinical trial for a mRNA-based vaccine against malaria. Sanofi Pasteur received approval for its dengue vaccine in the United States.These developments highlight the growing focus on personalized and innovative vaccine development, which is expected to drive the market's growth in the coming years.

Vaccine Research Market Segmentation

Vaccine Research Vaccine Type Outlook

• Live Attenuated Vaccines


• Inactivated Vaccines


• Recombinant Vaccines


• Conjugate Vaccines


• Subunit Vaccines


• Viral Vector Vaccines


• DNA Vaccines


• mRNA Vaccines

Vaccine Research Disease Prevention Outlook

• Infectious Diseases (e.g., Measles, Polio, Influenza)


• Chronic Diseases (e.g., Cancer, HIV/AIDS)


• Rare Diseases (e.g., Cystic Fibrosis, Hemophilia)

Vaccine Research Target Population Outlook

• Pediatrics


• Adults


• Elderly


• Pregnant Women

Vaccine Research Delivery Method Outlook

• Intramuscular Injection


• Subcutaneous Injection


• Intranasal Delivery


• Oral Administration

Vaccine Research Regional Outlook

• North America


• Europe


• South America


• Asia Pacific


• Middle East and Africa